In Endometriosis Treatment of Pain Due Levonorgestrel Releasing Intrauterine Vehicle System (LNG-IUD) to Event and Comparison Naproxen Sodium
Aim: Although there are many symptoms of endometriosis, the most frequent symptom is pain. The cause of pain is unknown. In this study, it is aimed to compare efficiency of LNG-IUD (levonorgestrel releasing...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mustafa Kemal University
2016-12-01
|
| Series: | Mustafa Kemal Üniversitesi Tıp Dergisi |
| Subjects: | |
| Online Access: | http://dergipark.gov.tr/mkutfd/issue/19607/287836?publisher=mku |
| Summary: | Aim: Although there are many symptoms of endometriosis,
the most frequent symptom is pain. The cause of pain is unknown. In this study,
it is aimed to compare efficiency of LNG-IUD (levonorgestrel releasing
intrauterine vehicle system) and the non-steroidal anti-inflammatory agent,
naproxen sodium which are two current approaches in the management of
endometriosis-related pain.Material and Methods: After approval of the Ethics
Committee, 60 patients, who were operated with the pathology of endometriosis,
were included in the study.It is divided into three groups and each group
cotained 20 patients.They are named as the control group, the LNG-IUD group,
and the naproxen sodium group. McGill pain questionnaire and pain questionnaire
form were given to patients monthly. Patients were asked to fill out the forms
using a visual analogue scale. Patients were followed-up monthly.Results: As a result of the statistical tests
applied, there was a significant decrease in the mean VAS score in the LNG- IUD
patient group from 1st to the 6th months of treatment. Reduction of pelvic pain
and dysmenorrhea was detected in the naproxen sodium group, but it did not
differ the decrease in pain severity between months
Conclusion: A number of medical drugs
are used in the management of endometriosis-related pain. It can be concluded
that LNG-IUD was a more effective due to modality in the management of
endometriosis-related pain, and has both low side effct and no need to be used
continously. |
|---|---|
| ISSN: | 2149-3103 |